Back to 
VIKING GLOBAL INVESTORS LP
VIKING GLOBAL INVESTORS LP
AMLX
Showing 0 of 9 quarters
Position history for VIKING GLOBAL INVESTORS LP's holdings in AMYLYX PHARMACEUTICALS INC
No. Viking Global Investors exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 2,962,555 shares worth $43.6M. Viking Global Investors already held AMLX in its Q1 2022 13F, the earliest on record, and held it in 8 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.